miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
出版年份 2019 全文链接
标题
miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
作者
关键词
miR-126-3p, melanoma, BRAF inhibitors, acquired resistance, proliferation, invasiveness
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-06-22
DOI
10.1186/s13046-019-1238-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Metazoan MicroRNAs
- (2018) David P. Bartel CELL
- MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers
- (2018) Casey L. Ross et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors
- (2018) Federica Baldassari et al. Frontiers in Genetics
- Encorafenib and Binimetinib: First Global Approvals
- (2018) Matt Shirley DRUGS
- MAPK pathway in melanoma part II—secondary and adaptive resistance mechanisms to BRAF inhibition
- (2017) Teresa Amaral et al. EUROPEAN JOURNAL OF CANCER
- The mitogen-activated protein kinase pathway in melanoma part I – Activation and primary resistance mechanisms to BRAF inhibition
- (2017) Teresa Amaral et al. EUROPEAN JOURNAL OF CANCER
- Survival of patients with advanced metastatic melanoma: the impact of novel therapies–update 2017
- (2017) Selma Ugurel et al. EUROPEAN JOURNAL OF CANCER
- MiR-126 reverses drug resistance to TRAIL through inhibiting the expression of c-FLIP in cervical cancer
- (2017) Weijiang Zhang et al. GENE
- The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells
- (2017) Maria Grazia Atzori et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research
- (2017) Nicola Silvestris et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
- (2017) Nico van Zandwijk et al. LANCET ONCOLOGY
- Integrating liquid biopsies into the management of cancer
- (2017) Giulia Siravegna et al. Nature Reviews Clinical Oncology
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway
- (2017) Lisa Koetz-Ploch et al. Pigment Cell & Melanoma Research
- Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib
- (2017) Simona Caporali et al. Oncotarget
- MicroRNAs in melanoma development and resistance to target therapy
- (2017) Luigi Fattore et al. Oncotarget
- Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF
- (2017) Jae-Hyeon Kim et al. Cancer Research and Treatment
- MicroRNA-126 increases chemosensitivity in drug-resistant gastric cancer cells by targeting EZH2
- (2016) Ping Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells
- (2016) R. Bhattacharya et al. CANCER RESEARCH
- VEGF blockade enhances the antitumor effect of BRAF V 600E inhibition
- (2016) Valentina Comunanza et al. EMBO Molecular Medicine
- Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
- (2016) Sarah J. Welsh et al. EUROPEAN JOURNAL OF CANCER
- A case for the use of receiver operating characteristic analysis of potential clinical efficacy biomarkers in advanced renal cell carcinoma
- (2016) Patricia A English et al. Future Oncology
- Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor
- (2016) Simona Caporali et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- MicroRNAs in colorectal carcinoma - from pathogenesis to therapy
- (2016) Yudan Chi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting microRNAs as key modulators of tumor immune response
- (2016) Laura Paladini et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MicroRNA-126 is downregulated in thyroid cancer cells, and regulates proliferation, migration and invasion by targeting CXCR4
- (2016) YAN QIAN et al. Molecular Medicine Reports
- Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
- (2016) Maxim V. Kuleshov et al. NUCLEIC ACIDS RESEARCH
- miR-579-3p controls melanoma progression and resistance to target therapy
- (2016) Luigi Fattore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach
- (2016) Daniela D’Arcangelo et al. Oncotarget
- microRNA Therapeutics in Cancer — An Emerging Concept
- (2016) Maitri Y. Shah et al. EBioMedicine
- Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
- (2015) Eishu Hirata et al. CANCER CELL
- Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance
- (2015) Willy Hugo et al. CELL
- Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
- (2015) Douglas B. Johnson et al. EUROPEAN JOURNAL OF CANCER
- MicroRNAs in melanocyte and melanoma biology
- (2015) Marina Mione et al. Pigment Cell & Melanoma Research
- miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment
- (2015) Shujing Liu et al. Pigment Cell & Melanoma Research
- Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
- (2015) Elisabetta Vergani et al. Oncotarget
- Predicting effective microRNA target sites in mammalian mRNAs
- (2015) Vikram Agarwal et al. eLife
- Melanoma
- (2015) Dirk Schadendorf et al. Nature Reviews Disease Primers
- Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical Data
- (2015) Patrick A. Ott et al. Frontiers in Oncology
- The Effect of Bevacizumab on Human Malignant Melanoma Cells with Functional VEGF/VEGFR2 Autocrine and Intracrine Signaling Loops
- (2015) Una Adamcic et al. NEOPLASIA
- WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors
- (2014) Jamie N. Anastas et al. JOURNAL OF CLINICAL INVESTIGATION
- Dynamics of Chemokine, Cytokine, and Growth Factor Serum Levels in BRAF-Mutant Melanoma Patients during BRAF Inhibitor Treatment
- (2014) J. S. Wilmott et al. JOURNAL OF IMMUNOLOGY
- Pretreatment Serum VEGF Is Associated with Clinical Response and Overall Survival in Advanced Melanoma Patients Treated with Ipilimumab
- (2014) J. Yuan et al. Cancer Immunology Research
- miR-126 in human cancers: Clinical roles and current perspectives
- (2013) Faeza Ebrahimi et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Host immunity contributes to the anti-melanoma activity of BRAF inhibitors
- (2013) Deborah A. Knight et al. JOURNAL OF CLINICAL INVESTIGATION
- Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer
- (2013) YU ZHANG et al. ONCOLOGY REPORTS
- miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma
- (2013) Nadia Felli et al. PLoS One
- miRWalk – Database: Prediction of possible miRNA binding sites by “walking” the genes of three genomes
- (2011) Harsh Dweep et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2
- (2011) Ni Zhu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy
- (2009) Marianna Sabatino et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma
- (2008) Faruk Tas et al. MEDICAL ONCOLOGY
- MeV+R: using MeV as a graphical user interface for Bioconductor applications in microarray analysis
- (2008) Vu T Chu et al. GENOME BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started